Oxford Nanopore opens new bioinformatics shop

With an eye toward recruiting top brains in informatics, Oxford Nanopore Technologies says that it has opened a new hub in Cambridge, U.K. The developer of DNA sequencers has also expanded its

Biomax Informatics expands deal with Royal DSM

German R&D software firm Biomax Informatics and Dutch chemical industry giant Royal DSM plan to expand a deal under which DSM will license Biomax's BioXM system for tools used in synthetic

Mayo Clinic eyes future trials recruitment with heath data exchange

Drug developers would love to be able to find qualified patients for their studies as easily as doing a Google search. While that might be a long way from becoming a reality, the Mayo Clinic has

Bioinformatics upstart Intervention Insights secures $7.2M

As community oncologists tackle the challenge of matching their patients with a growing menu of targeted drugs, start-up Intervention Insights has landed $7.2 million in venture financing to advance

Bracket buys ePRO provider Arrowhead

As patient reported outcomes become more common in clinical trials, eClinical software provider Bracket has bought Arrowhead Electronic Healthcare. Austin-based Arrowhead boosts the buyer's

Medidata faces market hurdles, Goldman says

Competition is mounting in the clinical trials software game, and drug developers are expected to temper their R&D spending in the coming years. These are two challenges that face major

Knome aids in Parkinson's gene discovery

Knome, a Cambridge, MA-based genome interpretation firm, used its proprietary DNA analysis software to help Canadian researchers uncover a gene variant that appears to be linked to late-onset

CRO Icon scoops up eClinical firm Firecrest

It's another CRO-eClinical marriage. Contract research giant Icon ($ICLR) said it has acquired Firecrest Clinical, which provides web-based tools for improving clinical trials site performance and

Accelrys integrates MIT tech into updated lab software

With the new release of its key life sciences modeling and simulation software, Accelrys ($ACCL) has added algorithms licensed from MIT that were developed to aid in the design of biologic drugs such

NCI taps start-up GNS's supercomputing tech for lung cancer analysis

The National Cancer Institute (NCI) wants to employ some supercomputers to help its researchers conquer lung cancer--the cancer causing the most deaths among Americans. GNS Healthcare, a provider of...

Two computational biology standouts honored

A pioneer and an up-and-comer in the field of computational biology have garnered awards from the International Society of Computational Biology. The first award, for a senior scientist in the field,

IBM cloud aids fight against superbugs

Big Blue's cloud has helped Swiss scientists in their hunt for clues about how certain bacteria form resistance against antibiotics and cause disease. It's perhaps the latest case where the tech

Health informatics giant Optum changes CEOs

UnitedHealth Group's $27 billion health information and technology business, Optum, has a new chief. Larry Renfro takes the top job as former Optum chief G. Mike Mikan departs to head an undisclosed

Sequencing giant BGI advances in bioinformatics game

BGI apparently isn't satisfied with being the largest genome sequencing outfit in the world. The Chinese sequencing giant has a host of new and updated bioinformatics software offerings, which appear

BioTox buys CRO Bio-Quant, eyes software integration

Two San Diego-based CROs are combining operations, and the buyer sees an opportunity to better serve its customers for preclinical services through integrating research software. BioTox Sciences has

Biomolecular computer shows promise in detecting disease

There's more progress in developing devices that use of biological molecules to compute information in our bodies to diagnose disease and release drugs. Researchers at the Weizmann Institute of

Open-source start-up TLS lands seed funding

CHICAGO -- Open-source drug development upstart Transparency Life Sciences has "raised a small seed round" of funding. It's using the funds to build an Internet presence, says Tomasz Sablinski, head

Hackers, some helpful, penetrate big-name pharma and healthcare

Bayer's Italian website was hacked in late June. And hacking group Lulz Security (LulzSec) penetrated the U.K.'s National Health Service earlier in the month, writes Stephanie Sutton of PharmTech

IBM, others herd trial data to cloud

The use of cloud computing for clinical data analysis appears to be catching on, says Patricia Dimond, a principal at BioInsight Consulting, in GEN. But some of the remaining tech hurdles--data

India trains IT savvy on drug trials, safety

India is ramping up in clinical data management and pharmacovigilance IT. Cognizant, Wipro and Accenture are all active in the country now and are offering services for one, the other, or both. And